Short Term Postoperative Tamponade Using Perfluorocarbon Liquid for Giant Retinal Tears

This study is currently recruiting participants.
Verified May 2012 by Ziv Hospital
Sponsor:
Information provided by (Responsible Party):
Ziv Hospital
ClinicalTrials.gov Identifier:
NCT01604616
First received: May 21, 2012
Last updated: May 22, 2012
Last verified: May 2012
  Purpose

The purpose of the article is, to investigate the efficacy and safety of perfluorocarbon liquid (PFCL) ,as a short term postoperative tamponade for treating retinal detachment ,associated with giant retinal tears.


Condition
Retinal Detachment

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Short Term Postoperative Tamponade Using Perfluorocarbon Liquid for Giant Retinal Tears

Resource links provided by NLM:


Further study details as provided by Ziv Hospital:

Estimated Enrollment: 40
Study Start Date: January 1998
Estimated Study Completion Date: June 2012
Groups/Cohorts
PCFL GROUP
patients in this group had the PFCL for a period of 7-10 days before it was replaced by SF6 gas or silicone oil
control group
in thos group no PFCL was left in the eye and either SF6 or silicone oil was the definitive treatment at the time of the retinal detachment surgery repair.

Detailed Description:

a retrospective study wich compared 2 groups that had giant tear repair in one group, PFCL was left for few days as an intermediate measure until silicone oil or SF6 gas was used to reattach the retina ,and in the control group SF6 or Silicone oil were used, with no PFCL.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

man and women above the age of 18 years

Criteria

Inclusion Criteria:

  • above 18 years of age
  • retinal tear at least of 3 clock hours.

Exclusion Criteria:

  • less than 18 years of age
  • Retinal tear less than 3 hours
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01604616

Locations
Israel
Ziv Medical Center Recruiting
Safed, Israel
Contact: Joseph Pikkel, M.D       pikel.y@ziv.health.gov.il   
Contact: Otzem Chassid, M.D       otzem.c@ziv.health.gov.il   
Sponsors and Collaborators
Ziv Hospital
Investigators
Principal Investigator: Joseph pikkel, M.D Ziv Medical Center
  More Information

No publications provided

Responsible Party: Ziv Hospital
ClinicalTrials.gov Identifier: NCT01604616     History of Changes
Other Study ID Numbers: 0032-12-ZIV
Study First Received: May 21, 2012
Last Updated: May 22, 2012
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Retinal Detachment
Retinal Perforations
Retinal Diseases
Eye Diseases

ClinicalTrials.gov processed this record on April 21, 2014